Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma is common among men as compared to women and also arises commonly with growing age.
Market Analysis and Insights: Global Multiple Myeloma Therapeutics Market
The global Multiple Myeloma Therapeutics market size is projected to reach US$ 30460 million by 2026, from US$ 27270 million in 2020, at a CAGR of 10.6%% during 2021-2026.
Global Multiple Myeloma Therapeutics Scope and Market Size
Multiple Myeloma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Myeloma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Janssen Biotech, Inc.
Bristol-Myers Squibb
Novartis AG
Bristol-Myers Squibb Company
Millennium Pharmaceuticals
Celgene Corporation
Kesios Therapeutics Limited
Amgene, Inc.
Genzyme Corporation
Juno Therapeutics
Chemotherapy And Other Drugs
Radiation
Stem Cell Transplant
Other Supportive Treatments
Hospitals
Clinics
Others
North America
Europe
China
Japan
Southeast Asia
India
Market Analysis and Insights: Global Multiple Myeloma Therapeutics Market
The global Multiple Myeloma Therapeutics market size is projected to reach US$ 30460 million by 2026, from US$ 27270 million in 2020, at a CAGR of 10.6%% during 2021-2026.
Global Multiple Myeloma Therapeutics Scope and Market Size
Multiple Myeloma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Myeloma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Janssen Biotech, Inc.
Bristol-Myers Squibb
Novartis AG
Bristol-Myers Squibb Company
Millennium Pharmaceuticals
Celgene Corporation
Kesios Therapeutics Limited
Amgene, Inc.
Genzyme Corporation
Juno Therapeutics
Market segment by Type, the product can be split into
Chemotherapy And Other Drugs
Radiation
Stem Cell Transplant
Other Supportive Treatments
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
